secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mineralys Therapeutics, Inc. (MLYS)
CIK:        0001933414
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001933414-24-000028
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Mineralys Therapeutics appoints Dr. Alexander Gold to board; Dr. Olivier Litzka resigns
--------------------------------------------------------------------------------

- Appointed Alexander M. Gold, M.D. as Class I director and to Nominating and Corporate Governance Committee, effective June 13, 2024.
- Dr. Gold received options to purchase 44,000 shares vesting over three years; cash compensation per non-employee director program.
- Dr. Olivier Litzka resigned from board effective June 13, 2024, with no disagreement with company or management.
- Board size decreased from eight to seven following resignation and prior departure of Alexander Asam, Ph.D. on May 22, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1933414/000193341424000028/0001933414-24-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1933414/000193341424000028/mlys-20240613.htm
  HTML page:      https://secwatch.observer/filing/0001933414-24-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer